E
Eric C. Seaberg
Researcher at Johns Hopkins University
Publications - 131
Citations - 9057
Eric C. Seaberg is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Multicenter AIDS Cohort Study & Hepatitis C. The author has an hindex of 46, co-authored 123 publications receiving 8487 citations. Previous affiliations of Eric C. Seaberg include University of Pittsburgh & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency Virus.
Alexander Breskin,Daniel Westreich,Stephen R. Cole,Michael G. Hudgens,Christopher B. Hurt,Eric C. Seaberg,Chloe L. Thio,Phyllis C. Tien,Adaora A. Adimora +8 more
TL;DR: HCV co-infection remains an important risk factor for mortality among PLwH after initiating antiretroviral therapy according to modern guidelines, and DAAs are effective at reducing mortality in this population.
Journal ArticleDOI
Association of IFNL3 and IFNL4 polymorphisms with liver-related mortality in a multiracial cohort of HIV/HCV-coinfected women
Monika Sarkar,B. Aouzierat,Peter Bacchetti,Ludmila Prokunina-Olsson,Audrey L. French,Eric C. Seaberg,Thomas R. O'Brien,Mark H. Kuniholm,Howard Minkoff,Michael Plankey,Howard D. Strickler,Marion G. Peters +11 more
TL;DR: The lower risk of death among African American HIV/HCV‐coinfected women is not explained by genetic variation in the IFN‐λ region suggesting, that other genetic, behavioural and/or environmental factors may contribute to racial/ethnic differences in liver‐related mortality.
Journal ArticleDOI
Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection.
Audrey L. French,Anna L. Hotton,Mary Young,Marek Nowicki,Michael Augenbraun,Kathryn Anastos,Eric C. Seaberg,William Rosenberg,Marion G. Peters +8 more
TL;DR: Isolated anti-HBc serologic status was not associated with accelerated liver disease progression over a median of 9.5 years among HIV/HCV-coinfected women, and factors independently associated with liver Disease progression were older age, lower CD4, antiretroviral therapy nonuse, and Hispanic ethnicity.
Journal ArticleDOI
Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection.
Jennifer C. Price,Eric C. Seaberg,John P. Phair,Mallory D. Witt,Susan L. Koletar,Chloe L. Thio +5 more
TL;DR: A protective effect of HAART decreased after 2 years, particularly in the HIV-monoinfected men, particularly on HIV suppression, and changes in the aspartate aminotransferase to platelet ratio index (APRI) increased before and post-HAART initiation.